Impact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations
- PMID: 39202343
- PMCID: PMC11353884
- DOI: 10.3390/genes15080982
Impact of Hepatitis Delta Virus Infection on the Selection of Hepatitis B Surface Antigen Mutations
Abstract
The interaction of multiple viruses in one host is thought to enhance the development of mutations. However, the impact of hepatitis D virus (HDV) positivity on the development of unique hepatitis B virus (HBV) mutations among people living with human immunodeficiency virus (HIV) (PLWH) remains poorly understood in African countries, including Botswana. We used HBV sequences generated from the Botswana Combination Prevention Project (BCPP), which is the largest pair-matched cluster-randomized HIV trial in Botswana. Only participants with available HBV sequences (n = 55) were included in our study ([HIV/HBV-positive (n = 50) and HIV/HBV/HDV-positive (n = 5)]. Geno2pheno was used to determine HBV genotypes, and HBV surface region sequences (all subgenotype A1) were aligned in AliView for mutational analysis, while the impact of mutations was assessed using Phyre2. Our results identified 182 common mutations between the two groups. In the HIV/HBV/HDV cohort, only three mutations (L95W, W156Q, C221Y) were classified as deleterious, with only L95W being the most frequent. In the HIV/HBV cohort, four mutations (W199R, C221A, C221S, W223G) were also classified as deleterious. Our results demonstrate the presence of unique HBV mutations among the HIV/HBV/HDV-positive cohort. Functional characterization of these mutations is recommended to determine their effect on HDV.
Keywords: Botswana; hepatitis B virus; hepatitis delta virus; mutations; people living with HIV.
Conflict of interest statement
The authors declare no conflicts of interest.
Figures
Similar articles
-
Hepatitis Delta Virus Clade 8 Is the Predominant Clade Circulating in Botswana amongst People Living with HIV.Viruses. 2024 Oct 4;16(10):1568. doi: 10.3390/v16101568. Viruses. 2024. PMID: 39459902 Free PMC article.
-
High prevalence of hepatitis delta virus among people with hepatitis B virus and HIV coinfection in Botswana.J Infect Public Health. 2023 Nov;16(11):1736-1741. doi: 10.1016/j.jiph.2023.08.011. Epub 2023 Aug 22. J Infect Public Health. 2023. PMID: 37734129 Free PMC article.
-
Prevalence, Risk Factors, and Clinical Profiles of Hepatitis D Virus in Nigeria: A Systematic Review, 2009-2024.Viruses. 2024 Oct 31;16(11):1723. doi: 10.3390/v16111723. Viruses. 2024. PMID: 39599836 Free PMC article.
-
Investigation of Hepatitis C, D, and HIV Seroprevalence and Evaluation of APRI and FIB-4 Scores in HbsAg-Positive Patients.Viruses. 2025 Apr 15;17(4):568. doi: 10.3390/v17040568. Viruses. 2025. PMID: 40285010 Free PMC article.
-
Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus.Cochrane Database Syst Rev. 2017 Feb 11;2(2):CD008545. doi: 10.1002/14651858.CD008545.pub2. Cochrane Database Syst Rev. 2017. PMID: 28188612 Free PMC article.
Cited by
-
Molecular Epidemiology, Drug-Resistant Variants, and Therapeutic Implications of Hepatitis B Virus and Hepatitis D Virus Prevalence in Nigeria: A National Study.Pathogens. 2025 Jan 20;14(1):101. doi: 10.3390/pathogens14010101. Pathogens. 2025. PMID: 39861062 Free PMC article.
References
-
- World Health Organization Hepatitis Delta Virus Fact Sheet. 2023. [(accessed on 20 February 2024)]. Available online: https://www.who.int/news-room/fact-sheets/detail/hepatitis-d.
-
- Hayashi T., Takeshita Y., Hutin Y.J.-F., Harmanci H., Easterbrook P., Hess S., van Holten J., Oru E.O., Kaneko S., Yurdaydin C., et al. The global hepatitis delta virus (HDV) epidemic: What gaps to address in order to mount a public health response? Arch. Public Health. 2021;79:180. doi: 10.1186/s13690-021-00693-2. - DOI - PMC - PubMed
-
- Arribas J.R., González-García J.J., Lorenzo A., Montero D., de Guevara C.L., Montes M., Hernández S., Pacheco R., Peña J.M., Vázquez J.J. Single (B or C), dual (BC or BD) and triple (BCD) viral hepatitis in HIV-infected patients in Madrid, Spain. AIDS. 2005;19:1361–1365. doi: 10.1097/01.aids.0000180787.10553.b2. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical